Silo Pharma, University to Explore Ways of Making MS Therapies More Effective

Silo Pharma, University to Explore Ways of Making MS Therapies More Effective

283117

Silo Pharma, University to Explore Ways of Making MS Therapies More Effective

Silo Pharma has entered into a sponsored research agreement with the University of Maryland to develop and explore the potential of a targeted therapy delivery system for multiple sclerosis (MS). The company and investigators at the Baltimore university will test a targeted therapy delivery approach that uses peptides — short chains of amino acids, the building blocks of proteins — to guide different therapeutic agents to the central nervous system (CNS; the brain and spinal cord).…

You must be logged in to read/download the full post.